Crohn's disease: open trials in Romania

14 open trials have a site in Romania. Registry data; only the trial team decides who can take part.

2024-518296-56-00
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Institutul Clinic Fundeni, Bucharest · Monza-Ares S.R.L., Bucharest · Dermastyle S.R.L., Bucharest · Gastro Med S R L, Cluj-Napoca · Spitalul Clinic Judeţean Mureş, Târgu Mureş · Asociatia Oncohelp, Timișoara
Registry updated 2026-11-06
NCT06226883
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Memorial Healthcare International S R L, Bucharest · Dermastyle S.R.L., Bucharest · Centrul Medical Sfanta Vineri S.R.L., Bucharest · Spitalul Clinic Colentina Bucuresti, Bucharest · Asociatia Oncohelp, Timișoara
Registry updated 2026-11-04
NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Spitalul Județean de Urgență Bacău, Bacau · Spitalul Universitar de Urgență București, Bucharest · Spitalul Clinic Colentina, Bucharest · Constanta County Emergency Clinical Hospital Sf.Ap.Andrei, Constanța · Spitalul Clinic Județean de Urgență, Craiova · S.C Centrul de Gastroenterologie Dr. Goldis S.R.L, Timișoara
Registry updated 2026-11-04
NCT07196722
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Spitalul Clinic Colentina Bucuresti, Bucharest · Delta Health Care S.R.L, Bucharest · Memorial Healthcare International S R L, Bucharest · Baneasa Tumor Center Hospital, Bucuresti · Institutul Regional De Gastroenterologie Hepatologie Prof. Dr. Octavian Fodor Cluj, Cluj-Napoca · Tvm Med Serv S.R.L., Cluj-Napoca · Gastromed S R L, Constanța · Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu
Registry updated 2026-11-03
NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Institutul Clinic Fundeni, Bucharest · Dermastyle S.R.L., Bucharest · Spitalul Clinic Colentina Bucuresti, Bucharest · Gastro Med S R L, Cluj-Napoca · Spitalul Clinic Judetean De Urgenta Sf. Spiridon Iasi, Jassi · Asociatia Oncohelp, Timișoara
Registry updated 2026-11-03
NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Takeda
Spitalul Clinic Dr. I. Cantacuzino, Bucharest · Institutul Clinic Fundeni, Bucharest · Delta Health Care S.R.L, Bucharest · Monza-Ares S.R.L., Bucharest · Spitalul Clinic Colentina Bucuresti, Bucharest · Valahia Medical S.R.L., Ploiesti · Cabinet Particular Policlinic Algomed S.R.L., Timisoara
Registry updated 2026-11-02
NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Dermastyle S.R.L., Bucharest · Institutul Clinic Fundeni, Bucharest · Monza-Ares S.R.L., Bucharest · Gastro Med S R L, Cluj-Napoca · Spitalul Clinic Judeţean Mureş, Târgu Mureş · Asociatia Oncohelp, Timișoara
Registry updated 2026-11-02
NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Tvm Med Serv S.R.L., Cluj-Napoca
Registry updated 2026-10-26
NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Spitalul Clinic Dr. I. Cantacuzino, Bucharest · Spitalul Clinic Colentina Bucuresti, Bucharest
Registry updated 2026-10-16
NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Dr. Victor Gomoiu Clinical Children Hospital, Bucharest · Spitalul Clinic de Urgenta Pentru Copii ,,Grigore Alexandrescu,, Bucharest · Spitalul Clinic Judetean De Urgenta Pius Brinzeu Timisoara, Timisoara
Registry updated 2026-10-09
NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Trial Treatment · Phase 2 · AbbVie
Spitalul Clinic Colentina Bucuresti, Bucharest · Memorial Healthcare International S R L, Bucharest · Gastro Med S R L, Cluj-Napoca · Asociatia Oncohelp, Timișoara
Registry updated 2026-09-25
NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Spitalul Clinic de Urgenta Pentru Copii ,,Grigore Alexandrescu,, Bucharest · Dr. Victor Gomoiu Clinical Children Hospital, Bucharest · Spitalul Clinic Judetean De Urgenta Pius Brinzeu Timisoara, Timisoara
Registry updated 2026-08-03
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Trial Treatment · Phase 2 · Takeda
Spitalul Clinic Colentina Bucuresti, Bucharest · Delta Health Care S.R.L, Bucharest · Institutul Clinic Fundeni, Bucharest · Memorial Healthcare International S R L, Bucharest · Monza-Ares S.R.L., Bucharest · Spitalul Clinic Dr. I. Cantacuzino, Bucharest · Cabinet Particular Policlinic Algomed S.R.L., Timisoara
Registry updated 2026-05-22
NCT06456593
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Abivax S.A.
Spitalul Clinic Colentina Bucuresti, Bucharest · Delta Health Care S.R.L, Bucharest · Monza-Ares S.R.L., Bucharest · Pelican Impex S.R.L., Oradea · Valahia Medical S.R.L., Ploiesti
Registry updated 2026-04-27

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error